ProMIS Neurosciences Inc. Common Shares (ON)
PMN Real Time Price USDRecent trades of PMN by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by PMN's directors and management
Government lobbying spending instances
Estimated quarterly lobbying spending
New patents grants
-
Patent Title: Fasr antibodies and methods of use Aug. 21, 2018
-
Patent Title: Methods and compositions to treat and detect misfolded-sod1 mediated diseases May. 02, 2017
-
Patent Title: Methods of diagnosing als Apr. 18, 2017
-
Patent Title: Detection of pathogenic abeta using an epitope protection assay Dec. 20, 2016
-
Patent Title: Antibodies and conjugates that target misfolded prion protein Mar. 29, 2016
Federal grants, loans, and purchases
Estimated quarterly amount awarded from public contracts
Number of mentions of PMN in WallStreetBets Daily Discussion
Recent insights relating to PMN
Recent picks made for PMN stock on CNBC
ETFs with the largest estimated holdings in PMN
|
Shareholder
|
Shares Held
|
|---|
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view PMN Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.